Cross-reactivity of anti-modified protein antibodies is also present in predisease and individuals without rheumatoid arthritis.

Autor: Reijm S; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands s.reijm@lumc.nl., Brehler AS; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands., Rantapää-Dahlqvist S; Department of Public Health and Clinical Medicine/Rheumatology, Umeå Universitet, Umea, Sweden., Kawakami A; Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan., Maeda T; Department of Community Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan., Kawashiri SY; Department of Immunology and Rheumatology Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan., Tamai M; Department of Immunology and Rheumatology Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan., van der Woude D; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands., Toes REM; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
Jazyk: angličtina
Zdroj: Annals of the rheumatic diseases [Ann Rheum Dis] 2022 Aug 11; Vol. 81 (9), pp. 1332-1334. Date of Electronic Publication: 2022 Aug 11.
DOI: 10.1136/annrheumdis-2022-222326
Abstrakt: Competing Interests: Competing interests: None declared.
Databáze: MEDLINE